Symbols

OPRX

Optimizerx·NASDAQ

--(--)

Signals Analysis

Bullish signal 7

Bearish signal 0

Consensus Rating "Strong Buy"

Ample Liquidity

High Gross Profit Margin

Significant Net Income Growth

High Cash/net Profit Ratio

Revenue Beats Expectation

EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About OPRX

Optimizerx Corp.

A developer of novel, orally administered therapies for the treatment of chronic diseases, with a focus on gastrointestinal and metabolic disorders

Industry

Healthcare Technology

Established Date

Listing Date

06/22/2018

Exchange

NASDAQ Stock Exchange

Full-time Employees

132

Fiscal Year Ends

12-31

Website

www.optimizerx.com

Security Type

Common stock

Office address

260 Charles Street Suite 302, Waltham, MA 02453

Business

Introduction

Optimizerx Corp. was founded in Nevada. Optimizerx is a digital health technology company that enables life science organizations, healthcare providers and patients to interact care-centered at critical moments throughout the patient care process. Optimizerx connects more than 60 percent of U.S. healthcare providers and millions of patients with an intelligent technology platform embedded in a proprietary point-of-care network, helping patients start and continue using their medicines.

Company Financials

EPS

OPRX has released its 2025 Q4 earnings. EPS was reported at 0.51, versus the expected 0.22, beating expectations. The chart below visualizes how OPRX has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

OPRX has released its 2025 Q4 earnings report, with revenue of 32.24M, reflecting a YoY change of -0.24%, and net profit of 5.02M, showing a YoY change of 6535.90%. The Sankey diagram below clearly presents OPRX's revenue sources and cost distribution.